Adagio Medical Holdings, Inc.

ADGM

Healthcare Medical Devices

Adagio Medical Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $602,000.00, up 100.7% from fiscal 2023.

Revenue
−33.5%
EPS
−15.4%
Free cash flow
−12.9%
Total debt
+46.6%

Quarter to June 2026, against a year earlier

0.06 0.00 0.00%
Market cap
$1.8M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
−74.6%
Net debt / EBITDA
−0.2×
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(657.76%) (268.88%) (155.25%) (208.48%)

+8 more TTM periods

ROA
(77.80%) (60.43%) (54.71%) (113.07%)
ROIC
(74.60%) (78.46%) (83.74%) (311.92%)
Return on Tangible Assets
(637.89%) (283.10%) (187.42%) (55,238.03%)
Average Days of Receivables
— — — —
Free Cash Flow per Share
(0.75) (0.72) (1.17) (1.53)
Free Cash Flow
(16.57) (15.97) (19.39) (23.55)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026